Edward K. Chow, Ph.D. - Publications

2007 University of California, Los Angeles, Los Angeles, CA 
Molecular Biology

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ho D, Quake SR, McCabe ERB, Chng WJ, Chow EK, Ding X, Gelb BD, Ginsburg GS, Hassenstab J, Ho CM, Mobley WC, Nolan GP, Rosen ST, Tan P, Yen Y, et al. Enabling Technologies for Personalized and Precision Medicine. Trends in Biotechnology. PMID 31980301 DOI: 10.1016/j.tibtech.2019.12.021  0.36
2018 Loh KP, Ho D, Chiu GNC, Leong DT, Pastorin G, Chow EK. Clinical Applications of Carbon Nanomaterials in Diagnostics and Therapy. Advanced Materials (Deerfield Beach, Fla.). e1802368. PMID 30133035 DOI: 10.1002/adma.201802368  0.36
2017 Lee DK, Kee T, Liang Z, Hsiou D, Miya D, Wu B, Osawa E, Chow EK, Sung EC, Kang MK, Ho D. Clinical validation of a nanodiamond-embedded thermoplastic biomaterial. Proceedings of the National Academy of Sciences of the United States of America. PMID 29078364 DOI: 10.1073/pnas.1711924114  0.36
2016 Ho D, Zarrinpar A, Chow EK. Diamonds, Digital Health, and Drug Development: Optimizing Combinatorial Nanomedicine. Acs Nano. PMID 27682869 DOI: 10.1021/acsnano.6b06174  0.36
2016 Moore L, Yang J, Lan TT, Osawa E, Lee DK, Johnson WD, Xi JJ, Chow EK, Ho D. Biocompatibility Assessment of Detonation Nanodiamond in Non-Human Primates and Rats Using Histological, Hematologic and Urine Analysis. Acs Nano. PMID 27439019 DOI: 10.1021/acsnano.6b00839  0.36
2015 Ho D, Wang CK, Chow EK. Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine. Science Advances. 1: e1500439. PMID 26601235 DOI: 10.1126/sciadv.1500439  0.36
2015 Mitragotri S, Anderson DG, Chen X, Chow EK, Ho D, Kabanov AV, Karp JM, Kataoka K, Mirkin CA, Petrosko SH, Shi J, Stevens MM, Sun S, Teoh S, Venkatraman SS, et al. Accelerating the Translation of Nanomaterials in Biomedicine. Acs Nano. PMID 26115196 DOI: 10.1021/acsnano.5b03569  0.36
2015 Mohd Abdul Rashid MB, Toh TB, Silva A, Nurrul Abdullah L, Ho CM, Ho D, Chow EK. Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas. Journal of Laboratory Automation. 20: 423-37. PMID 25824204 DOI: 10.1177/2211068215579612  0.36
2014 Ho D, Chow EK. Introducing the 2014 JALA Ten Honorees. Journal of Laboratory Automation. 19: 119-124. PMID 28075673 DOI: 10.1177/2211068213516565  0.36
2014 Ho D, Chow EK. Automation Highlights from the Literature. Journal of Laboratory Automation. 19: 215-217. PMID 28075187 DOI: 10.1177/2211068214524922  0.36
2014 Wang X, Low XC, Hou W, Abdullah LN, Toh TB, Mohd Abdul Rashid M, Ho D, Chow EK. Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells. Acs Nano. 8: 12151-66. PMID 25437772 DOI: 10.1021/nn503491e  0.36
2014 Tsai N, Lee B, Kim A, Yang R, Pan R, Lee DK, Chow EK, Ho D. Nanomedicine for global health. Journal of Laboratory Automation. 19: 511-6. PMID 24902713 DOI: 10.1177/2211068214538263  0.96
2014 Toh TB, Lee DK, Hou W, Abdullah LN, Nguyen J, Ho D, Chow EK. Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells. Molecular Pharmaceutics. 11: 2683-91. PMID 24867631 DOI: 10.1021/mp5001108  0.96
2014 Man HB, Kim H, Kim HJ, Robinson E, Liu WK, Chow EK, Ho D. Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 359-69. PMID 23916889 DOI: 10.1016/j.nano.2013.07.014  0.96
2014 Man H, Sasine J, Chow EK, Ho D. Nanodiamonds for drug delivery and diagnostics Rsc Nanoscience and Nanotechnology. 2014: 151-169.  0.96
2013 Chow EK, Ho D. Cancer nanomedicine: from drug delivery to imaging. Science Translational Medicine. 5: 216rv4. PMID 24353161 DOI: 10.1126/scitranslmed.3005872  0.36
2013 Moore L, Chow EK, Osawa E, Bishop JM, Ho D. Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression. Advanced Materials (Deerfield Beach, Fla.). 25: 3532-41. PMID 23584895 DOI: 10.1002/adma.201300343  0.96
2012 Chow EK, Fan LL, Chen X, Bishop JM. Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells. Hepatology (Baltimore, Md.). 56: 1331-41. PMID 22505225 DOI: 10.1002/hep.25776  0.96
2012 Man HB, Zhang K, Robinson E, Chow EK, Ho D. Engineering Nanoparticulate Diamond for Applications in Nanomedicine and Biology Ultrananocrystalline Diamond: Synthesis, Properties and Applications: Second Edition. 493-518. DOI: 10.1016/B978-1-4377-3465-2.00015-3  0.96
2011 Zhang XQ, Lam R, Xu X, Chow EK, Kim HJ, Ho D. Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy. Advanced Materials (Deerfield Beach, Fla.). 23: 4770-5. PMID 21932280 DOI: 10.1002/adma.201102263  0.96
2011 Smith AH, Robinson EM, Zhang XQ, Chow EK, Lin Y, Osawa E, Xi J, Ho D. Triggered release of therapeutic antibodies from nanodiamond complexes. Nanoscale. 3: 2844-8. PMID 21617824 DOI: 10.1039/c1nr10278h  0.96
2011 Ghaffari AA, Chow EK, Iyer SS, Deng JC, Cheng G. Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3. Hepatology (Baltimore, Md.). 53: 2042-52. PMID 21433044 DOI: 10.1002/hep.24316  0.96
2011 Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Science Translational Medicine. 3: 73ra21. PMID 21389265 DOI: 10.1126/scitranslmed.3001713  0.96
2010 Chen M, Zhang XQ, Man HB, Lam R, Chow EK, Ho D. Nanodiamond vectors functionalized with polyethylenimine for siRNA delivery Journal of Physical Chemistry Letters. 1: 3167-3171. DOI: 10.1021/jz1013278  0.96
2009 Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. The Journal of Clinical Investigation. 119: 1910-20. PMID 19487810 DOI: 10.1172/JCI35412  0.96
2008 Chow EK, Pierstorff E, Cheng G, Ho D. Copolymeric nanofilm platform for controlled and localized therapeutic delivery. Acs Nano. 2: 33-40. PMID 19206545 DOI: 10.1021/nn7000917  0.96
2007 Chow EK, Razani B, Cheng G. Innate immune system regulation of nuclear hormone receptors in metabolic diseases. Journal of Leukocyte Biology. 82: 187-95. PMID 17314330 DOI: 10.1189/jlb.1206741  0.96
2007 Chow EK, Pierstorff E, Cheng G, Tai YC, Ho D. Attenuation of cellular inflammation using glucocorticoid-functionalized copolymers Proceedings of the 2nd Ieee International Conference On Nano/Micro Engineered and Molecular Systems, Ieee Nems 2007. 1039-1043. DOI: 10.1109/NEMS.2007.352195  0.96
2006 Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, Tontonoz P, Cheng G. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. The Journal of Experimental Medicine. 203: 2589-602. PMID 17074929 DOI: 10.1084/jem.20060929  0.96
2005 Chow EK, O'connell RM, Schilling S, Wang XF, Fu XY, Cheng G. TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk. The Embo Journal. 24: 4071-81. PMID 16308570 DOI: 10.1038/sj.emboj.7600867  0.96
2004 Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. The Journal of Experimental Medicine. 199: 1651-8. PMID 15210743 DOI: 10.1084/jem.20040528  0.96
2004 Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G. Toll-like receptors induce a phagocytic gene program through p38. The Journal of Experimental Medicine. 199: 81-90. PMID 14699082 DOI: 10.1084/jem.20031237  0.96
2003 Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. Journal of Immunology (Baltimore, Md. : 1950). 170: 3565-71. PMID 12646618  0.96
Show low-probability matches.